Katharina Nobis-Esser
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation" [J Hepatol (2023) 645-656].
Journal: Journal of hepatology
Published: December 01, 2023
Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation.
Journal: Journal of hepatology
Published: December 23, 2022
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture.
Journal: Nature microbiology
Published: January 24, 2017
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture.
Journal: Nature microbiology
Published: August 17, 2016
Type I and type II interferon responses in two human liver cell lines (Huh-7 and HuH6).
Journal: Genomics data
Published: December 11, 2015
The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8(+) T cell activation.
Journal: Journal of hepatology
Published: December 02, 2015
Novel perspectives for hepatitis A virus therapy revealed by comparative analysis of hepatitis C virus and hepatitis A virus RNA replication.
Journal: Hepatology (Baltimore, Md.)
Published: February 17, 2015
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor.
Journal: Journal of hepatology
Published: September 06, 2013
Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.
Journal: Hepatology (Baltimore, Md.)
Published: July 10, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026